<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>GBIHealth | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-28T11:44:27+08:00</updated>
  <subtitle>GBI专注于中国市场，为药企、器械企业和其他服务提供商建立多元的市场情报解决方案组合。GBI的高附加值行业信息、新闻和数据服务能力帮助个人和组织做出以数据为驱动的决策，更高效地沟通。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>专题报告 | 带量采购和医保双重挤压下药企破局之路</title>
    <updated>2020-12-27T19:05:54+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-27:/s/josBs-KHkRIWRrwiAFZJ1w</id>
    <link href="https://mp.weixin.qq.com/s/josBs-KHkRIWRrwiAFZJ1w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>第四批国家药品集中采购正式启动！诺诚健华BTK抑制剂奥布替尼获批；协和发酵麒麟与维健医药达成合作</title>
    <updated>2020-12-27T19:05:54+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-27:/s/-VD6m_EG9vhAt_xSFM9hfg</id>
    <link href="https://mp.weixin.qq.com/s/-VD6m_EG9vhAt_xSFM9hfg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>DEVINT | 卡尤迪完成近6亿元D轮融资；豪思生物完成数亿元人民币B轮融资</title>
    <updated>2020-12-27T19:05:54+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-27:/s/xEV2gQT6JQTwwm_m1y7tvg</id>
    <link href="https://mp.weixin.qq.com/s/xEV2gQT6JQTwwm_m1y7tvg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>触及带量采购临界点！吗替麦考酚酯双品通过一致性评价</title>
    <updated>2020-12-25T21:55:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-25:/s/nfAVPf2VazPEq7yH2k5vSQ</id>
    <link href="https://mp.weixin.qq.com/s/nfAVPf2VazPEq7yH2k5vSQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>圣诞大放送！医保谈判万众瞩目是“她”，大佬独宠重金押注是“她”，2021年“她”也会更难吗？</title>
    <updated>2020-12-24T21:05:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-24:/s/eB_uKh7K2isyRRG65wgA7A</id>
    <link href="https://mp.weixin.qq.com/s/eB_uKh7K2isyRRG65wgA7A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2021年抗癌药、罕见病药零关税名单公布；艾德生物与默克达成合作；阿斯利康/第一三共、拜耳等药物进入突破性治疗程序</title>
    <updated>2020-12-24T21:05:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-24:/s/3TrDAhKghxq-6DpCX98gaQ</id>
    <link href="https://mp.weixin.qq.com/s/3TrDAhKghxq-6DpCX98gaQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>DEVINT | 美敦力与新光维医疗合作推动国产内窥镜技术落地；臻和生物与高博医疗就血液肿瘤精准诊疗达成合作</title>
    <updated>2020-12-24T21:05:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-24:/s/NpbebWeHajAVTIsp1lJ-Ew</id>
    <link href="https://mp.weixin.qq.com/s/NpbebWeHajAVTIsp1lJ-Ew" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>官宣！前武田业务负责人出任北海康成中国区总经理</title>
    <updated>2020-12-23T17:34:59+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-23:/s/B6zkX94dfhzH-g6aP5ywPQ</id>
    <link href="https://mp.weixin.qq.com/s/B6zkX94dfhzH-g6aP5ywPQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>率先追平修美乐，信达阿达木单抗集齐6个适应症！阿斯利康一III期研究失利；亘喜生物拟纳斯达克上市</title>
    <updated>2020-12-23T17:34:59+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-23:/s/3tL5dzR9GP-VN90c0VsjDw</id>
    <link href="https://mp.weixin.qq.com/s/3tL5dzR9GP-VN90c0VsjDw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>DEVINT | 瑞朗泰科完成近亿元A轮融资；福寿康完成数千万美元B轮融资</title>
    <updated>2020-12-23T17:34:59+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-23:/s/At4f7VR96JADLXch8nE-kg</id>
    <link href="https://mp.weixin.qq.com/s/At4f7VR96JADLXch8nE-kg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>卖卖卖！裁裁裁！又一知名外企出售其非核心业务</title>
    <updated>2020-12-22T19:02:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-22:/s/keLTh2-wo7pNAB_tpv8kyw</id>
    <link href="https://mp.weixin.qq.com/s/keLTh2-wo7pNAB_tpv8kyw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>东阳光抗丙肝1类新药获批上市；罗氏双特异性抗体达3期临床主要终点；传奇生物将获杨森7500万美元里程碑付款</title>
    <updated>2020-12-22T19:02:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-22:/s/XxKTh7zOyDOjuedsam0krA</id>
    <link href="https://mp.weixin.qq.com/s/XxKTh7zOyDOjuedsam0krA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>DEVINT | 一次性内窥镜制造商瑞派医疗完成近亿元A轮融资；苏州彩科获数千万元A轮融资</title>
    <updated>2020-12-22T19:02:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-22:/s/KVu9QxapB9Yel8nnstq1nw</id>
    <link href="https://mp.weixin.qq.com/s/KVu9QxapB9Yel8nnstq1nw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>辉瑞专利未到期，齐鲁首仿已获批</title>
    <updated>2020-12-21T21:58:15+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-21:/s/3sokYHz4obMkC8KoWrwV8g</id>
    <link href="https://mp.weixin.qq.com/s/3sokYHz4obMkC8KoWrwV8g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>诺华重磅RNAi降脂药美国上市推迟；德琪医药抗癌药中国获批3期临试，在美新适应症获批；GSK、诺华、赛生近日重磅交易</title>
    <updated>2020-12-21T21:58:15+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-21:/s/sE5lZGji8AytNE9tMK3eEw</id>
    <link href="https://mp.weixin.qq.com/s/sE5lZGji8AytNE9tMK3eEw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>DEVINT | 国家药监局11月批准注册121个医疗器械产品；沛嘉医疗与HigLife SAS达成合作</title>
    <updated>2020-12-21T21:58:15+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-21:/s/22la0ItOfoJePP3P48W4-w</id>
    <link href="https://mp.weixin.qq.com/s/22la0ItOfoJePP3P48W4-w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>专题报告 | 肿瘤药蓝海：乐城先行区特权引进和创新保险实践</title>
    <updated>2020-12-20T18:53:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-20:/s/raX3dclzyvYu-eHMCRWiDw</id>
    <link href="https://mp.weixin.qq.com/s/raX3dclzyvYu-eHMCRWiDw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>三款1类新药拟纳入突破性治疗品种；武田血友病管理工具中国上市；FDA批准首款狼疮性肾炎疗法</title>
    <updated>2020-12-20T18:53:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-20:/s/q-wkE-tJaBWijXVK2Dsnig</id>
    <link href="https://mp.weixin.qq.com/s/q-wkE-tJaBWijXVK2Dsnig" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>DEVINT | 国家医保局再发文推进冠脉支架集采中选结果在全国落地；科兴中维、北京生物新冠疫苗200元/支在江苏中标</title>
    <updated>2020-12-20T18:53:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-20:/s/PMrSQjXkKK6gEDZCm3YBnw</id>
    <link href="https://mp.weixin.qq.com/s/PMrSQjXkKK6gEDZCm3YBnw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>期刊杂志 | 第152期CPB Review：引进境外特许药超100种，乐城先行区了解一下；VBP、医保对MNC业绩增长压力渐显</title>
    <updated>2020-12-17T17:25:10+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-17:/s/gkL44PWTOBG-XbvQ_PprnA</id>
    <link href="https://mp.weixin.qq.com/s/gkL44PWTOBG-XbvQ_PprnA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>